药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Drostanolone
Rindopepimut
The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Decitabine.
Drostanolone
INGN 225
The therapeutic efficacy of INGN 225 can be decreased when used in combination with Decitabine.
Drostanolone
PEV3A
The therapeutic efficacy of PEV3A can be decreased when used in combination with Decitabine.
Drostanolone
G17DT
The therapeutic efficacy of G17DT can be decreased when used in combination with Decitabine.
Drostanolone
Fingolimod
Decitabine may increase the immunosuppressive activities of Fingolimod.
Drostanolone
Tofacitinib
Decitabine may increase the immunosuppressive activities of Tofacitinib.
Drostanolone
Metamizole
The risk or severity of myelosuppression can be increased when Metamizole is combined with Decitabine.
Drostanolone
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Decitabine.
Drostanolone
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Decitabine.
Drostanolone
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Decitabine.
Drostanolone
Roflumilast
Roflumilast may increase the immunosuppressive activities of Decitabine.
Drostanolone
Difluocortolone
The risk or severity of adverse effects can be increased when Decitabine is combined with Difluocortolone.
Drostanolone
Clobetasol
The risk or severity of adverse effects can be increased when Decitabine is combined with Clobetasol.
Drostanolone
Fluocortolone
The risk or severity of adverse effects can be increased when Decitabine is combined with Fluocortolone.
Drostanolone
Hydrocortisone butyrate
The risk or severity of adverse effects can be increased when Decitabine is combined with Hydrocortisone butyrate.
Drostanolone
Fluocinonide
The risk or severity of adverse effects can be increased when Fluocinonide is combined with Decitabine.
Drostanolone
Clobetasol propionate
The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Decitabine.
Drostanolone
Bleselumab
The risk or severity of adverse effects can be increased when Decitabine is combined with Bleselumab.
Drostanolone
Rozanolixizumab
The risk or severity of adverse effects can be increased when Decitabine is combined with Rozanolixizumab.
Drostanolone
Risankizumab
The risk or severity of adverse effects can be increased when Decitabine is combined with Risankizumab.